This article is more than 5 years old. Information may no longer be current.
Cardiology Today’s coverage of triglyceride awareness includes REDUCE-IT, lipid screening
In recognition of National Triglycerides Day, founded in 2018 to encourage awareness of healthy triglyceride levels and the role they play in a healthy lifestyle, Cardiology Today has compiled a list of several stories discussing the importance of maintaining healthy triglyceride levels.
An analysis of the REDUCE-IT study finding that icosapent ethyl reduced total ischemic events in patients with high triglycerides and an emphasis on lipid screening are among some of topics featured.
Prescription fish oil cuts total ischemic events in new REDUCE-IT analysis
Icosapent ethyl, a pharmaceutical-grade omega-3 fatty acid, was in the spotlight again at the American College of Cardiology Scientific Session, with new data from the REDUCE-IT trial demonstrating a 30% reduction in total ischemic events, including first and subsequent events, in high-risk patients with elevated triglycerides.
‘Missed opportunity’: Most pregnant women do not undergo lipid screening
NEW ORLEANS — Lipid screening was underutilized in women during pregnancy, with a new study suggesting that up to three-quarters of women were not screened and that 13% of those who were screened had elevated triglycerides.
DeMaria: Several recent trials have implications for clinical practice
WASHINGTON — Some of the top studies in 2018 that may have implications on clinical practice include those that focus on patients with mitral regurgitation, HF, high triglycerides and hypertension, according to a presentation at Cardiovascular Research Technologies.
New trial data show mixed findings for omega-3s
The growth in popularity of omega-3 supplementation — typically a combination of eicosapentaenoic acid and docosahexaenoic acid — follows years of research suggesting benefits for a range of conditions, from brain and eye health to reducing risk for CVD — possibly via a mechanism of triglyceride reduction — or cancer.
High triglycerides raise risk for peripheral artery revascularization
MUNICH — Among high-risk patients on statin treatment, those with elevated triglycerides were more likely to undergo peripheral artery revascularization within 5 years, researchers reported at the European Society of Cardiology Congress.
Routine lipid testing confers greater adherence to optimal therapy, lower LDL levels
Patients who undergo testing of lipid levels, including triglycerides, appear to be more likely to adhere to the 2013 American College of Cardiology/American Heart Association cholesterol guidelines, including treatment with a statin medication, a high-intensity statin and nonstatin lipid-lowering therapy, according to a study published in the Journal of the American Heart Association.
Cholesterol guidelines updated with newer medications, more personalized risk calculation
CHICAGO — New cholesterol guidelines from the American Heart Association, American College of Cardiology and 10 other societies recommend a stepped approach including statins, ezetimibe and PCSK9 inhibitors in patients with prior CVD at very high risk for another event. According to the guidelines, elevated triglycerides may be used as a risk-enhancing factor to help determine if a patient should begin statin therapy.